Product Details for: Novolog Mix 70/30

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injectable Suspension
Subcutaneous
700UNITS/10ML (70UNITS/ML); 300UNITS/10ML (30UNITS/ML)
Multi-Dose Vial
351(a)
Novolog Mix 70/30
Rx
002
Injectable Suspension
Subcutaneous
210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML)
Autoinjector
351(a)
Novolog Mix 70/30
Disc
003
Injectable Suspension
Subcutaneous
210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML)
Pre-Filled Syringe
351(a)
Novolog Mix 70/30
Disc
004
Injectable Suspension
Subcutaneous
210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML)
Autoinjector
351(a)
Novolog Mix 70/30
Rx
Proper Name
insulin aspart protamine and insulin aspart
BLA Number
021172
Applicant
Novo Nordisk Inc.
Original Approval Date
November 1, 2001
Date of First Licensure
RETURN TO SEARCH RESULTS